,outcome,arm 1,arm 2
0,intervention,,placebo group
0,"daily dose, persons completing the study",NR,2.9+/-1.4 mg
0,persons completing the study,NR,none of 16 in
0,"daily dose, persons completing the study, total study group",8 ( 57 % ) of 14 patients,8 ( 57 % ) of 14 patients
